AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.36-1.87 (-1.78%) ▼|ACN177.91+2.11 (+1.20%) ▲|ADBE248.83-6.03 (-2.37%) ▼|AMAT454.01-14.84 (-3.17%) ▼|AMD503.60-17.50 (-3.36%) ▼|AMGN382.47-8.80 (-2.25%) ▼|AMT172.98-2.45 (-1.40%) ▼|AMZN251.89-0.51 (-0.20%) ▼|AVGO360.83-3.55 (-0.97%) ▼|AXP320.71-1.09 (-0.34%) ▼|BA204.80-1.62 (-0.78%) ▼|BAC62.56-0.11 (-0.18%) ▼|BKNG174.33+0.90 (+0.52%) ▲|BLK1,062.40-9.63 (-0.90%) ▼|BMY63.75-0.66 (-1.02%) ▼|BNY162.59+0.08 (+0.05%) ▲|BRK-B507.00+0.28 (+0.06%) ▲|C138.50+0.70 (+0.51%) ▲|CAT805.00-10.56 (-1.29%) ▼|CL87.90-0.13 (-0.15%) ▼|CMCSA25.17+0.58 (+2.36%) ▲|COF207.11-3.75 (-1.78%) ▼|COP137.04+0.51 (+0.37%) ▲|COST902.38-0.22 (-0.02%) ▼|CRM243.00-1.16 (-0.48%) ▼|CSCO107.44-1.99 (-1.82%) ▼|CVS95.29-0.09 (-0.09%) ▼|CVX212.76-1.05 (-0.49%) ▼|DE677.94+0.73 (+0.11%) ▲|DHR200.53-4.32 (-2.11%) ▼|DIS105.82+1.64 (+1.57%) ▲|DUK119.37-1.06 (-0.88%) ▼|EMR148.37-1.97 (-1.31%) ▼|FDX311.80+2.61 (+0.84%) ▲|GD354.25+1.58 (+0.45%) ▲|GE324.15-1.27 (-0.39%) ▼|GEV923.91-27.13 (-2.85%) ▼|GILD144.81-0.84 (-0.58%) ▼|GM86.12+2.36 (+2.82%) ▲|GOOG330.39+2.01 (+0.61%) ▲|GOOGL332.60+1.95 (+0.59%) ▲|GS1,019.77-9.01 (-0.88%) ▼|HD305.69-4.76 (-1.53%) ▼|HON202.18-2.75 (-1.34%) ▼|IBM234.02-5.92 (-2.47%) ▼|INTC100.32-5.92 (-5.57%) ▼|INTU312.77-1.17 (-0.37%) ▼|ISRG360.46+7.22 (+2.04%) ▲|JNJ266.35-0.73 (-0.27%) ▼|JPM353.56-1.15 (-0.32%) ▼|KO87.83+0.28 (+0.32%) ▲|LIN461.62-5.03 (-1.08%) ▼|LLY1,123.00-1.21 (-0.11%) ▼|LMT530.12+5.66 (+1.08%) ▲|LOW196.59-2.01 (-1.01%) ▼|LRCX298.01-17.83 (-5.65%) ▼|MA565.37-2.13 (-0.38%) ▼|MCD253.05-0.43 (-0.17%) ▼|MDLZ62.47+0.05 (+0.08%) ▲|MDT91.62-0.27 (-0.29%) ▼|META644.38-9.31 (-1.42%) ▼|MMM162.86-1.54 (-0.94%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.71-2.82 (-1.91%) ▼|MS212.66-2.69 (-1.25%) ▼|MSFT492.44+0.79 (+0.16%) ▲|MU977.41-50.36 (-4.90%) ▼|NEE82.44-0.21 (-0.25%) ▼|NFLX76.01-0.02 (-0.03%) ▼|NKE36.62-0.73 (-1.95%) ▼|NOW131.17+0.06 (+0.05%) ▲|NVDA218.36-5.31 (-2.37%) ▼|ORCL152.94-8.69 (-5.38%) ▼|PEP136.65-0.04 (-0.03%) ▼|PFE27.65-0.13 (-0.47%) ▼|PG142.97+0.33 (+0.23%) ▲|PLTR165.86-3.67 (-2.16%) ▼|PM189.77+4.06 (+2.19%) ▲|QCOM176.88+0.48 (+0.27%) ▲|RTX198.12+0.57 (+0.29%) ▲|SBUX99.22-0.82 (-0.82%) ▼|SCHW107.33+0.79 (+0.74%) ▲|SO87.75-0.59 (-0.67%) ▼|SPG204.67+0.14 (+0.07%) ▲|T25.55+0.40 (+1.59%) ▲|TMO603.18-2.51 (-0.41%) ▼|TMUS177.16-0.18 (-0.10%) ▼|TSLA363.56-4.25 (-1.16%) ▼|TXN258.82-2.77 (-1.06%) ▼|UBER72.56+1.48 (+2.08%) ▲|UNH388.28-4.78 (-1.22%) ▼|UNP285.78+1.04 (+0.37%) ▲|UPS99.97+0.75 (+0.76%) ▲|USB62.41+0.30 (+0.48%) ▲|V367.21-0.18 (-0.05%) ▼|VZ49.97+0.23 (+0.46%) ▲|WFC89.45-0.22 (-0.25%) ▼|WMT105.73-0.10 (-0.09%) ▼|XOM165.23+1.00 (+0.61%) ▲|AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.36-1.87 (-1.78%) ▼|ACN177.91+2.11 (+1.20%) ▲|ADBE248.83-6.03 (-2.37%) ▼|AMAT454.01-14.84 (-3.17%) ▼|AMD503.60-17.50 (-3.36%) ▼|AMGN382.47-8.80 (-2.25%) ▼|AMT172.98-2.45 (-1.40%) ▼|AMZN251.89-0.51 (-0.20%) ▼|AVGO360.83-3.55 (-0.97%) ▼|AXP320.71-1.09 (-0.34%) ▼|BA204.80-1.62 (-0.78%) ▼|BAC62.56-0.11 (-0.18%) ▼|BKNG174.33+0.90 (+0.52%) ▲|BLK1,062.40-9.63 (-0.90%) ▼|BMY63.75-0.66 (-1.02%) ▼|BNY162.59+0.08 (+0.05%) ▲|BRK-B507.00+0.28 (+0.06%) ▲|C138.50+0.70 (+0.51%) ▲|CAT805.00-10.56 (-1.29%) ▼|CL87.90-0.13 (-0.15%) ▼|CMCSA25.17+0.58 (+2.36%) ▲|COF207.11-3.75 (-1.78%) ▼|COP137.04+0.51 (+0.37%) ▲|COST902.38-0.22 (-0.02%) ▼|CRM243.00-1.16 (-0.48%) ▼|CSCO107.44-1.99 (-1.82%) ▼|CVS95.29-0.09 (-0.09%) ▼|CVX212.76-1.05 (-0.49%) ▼|DE677.94+0.73 (+0.11%) ▲|DHR200.53-4.32 (-2.11%) ▼|DIS105.82+1.64 (+1.57%) ▲|DUK119.37-1.06 (-0.88%) ▼|EMR148.37-1.97 (-1.31%) ▼|FDX311.80+2.61 (+0.84%) ▲|GD354.25+1.58 (+0.45%) ▲|GE324.15-1.27 (-0.39%) ▼|GEV923.91-27.13 (-2.85%) ▼|GILD144.81-0.84 (-0.58%) ▼|GM86.12+2.36 (+2.82%) ▲|GOOG330.39+2.01 (+0.61%) ▲|GOOGL332.60+1.95 (+0.59%) ▲|GS1,019.77-9.01 (-0.88%) ▼|HD305.69-4.76 (-1.53%) ▼|HON202.18-2.75 (-1.34%) ▼|IBM234.02-5.92 (-2.47%) ▼|INTC100.32-5.92 (-5.57%) ▼|INTU312.77-1.17 (-0.37%) ▼|ISRG360.46+7.22 (+2.04%) ▲|JNJ266.35-0.73 (-0.27%) ▼|JPM353.56-1.15 (-0.32%) ▼|KO87.83+0.28 (+0.32%) ▲|LIN461.62-5.03 (-1.08%) ▼|LLY1,123.00-1.21 (-0.11%) ▼|LMT530.12+5.66 (+1.08%) ▲|LOW196.59-2.01 (-1.01%) ▼|LRCX298.01-17.83 (-5.65%) ▼|MA565.37-2.13 (-0.38%) ▼|MCD253.05-0.43 (-0.17%) ▼|MDLZ62.47+0.05 (+0.08%) ▲|MDT91.62-0.27 (-0.29%) ▼|META644.38-9.31 (-1.42%) ▼|MMM162.86-1.54 (-0.94%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.71-2.82 (-1.91%) ▼|MS212.66-2.69 (-1.25%) ▼|MSFT492.44+0.79 (+0.16%) ▲|MU977.41-50.36 (-4.90%) ▼|NEE82.44-0.21 (-0.25%) ▼|NFLX76.01-0.02 (-0.03%) ▼|NKE36.62-0.73 (-1.95%) ▼|NOW131.17+0.06 (+0.05%) ▲|NVDA218.36-5.31 (-2.37%) ▼|ORCL152.94-8.69 (-5.38%) ▼|PEP136.65-0.04 (-0.03%) ▼|PFE27.65-0.13 (-0.47%) ▼|PG142.97+0.33 (+0.23%) ▲|PLTR165.86-3.67 (-2.16%) ▼|PM189.77+4.06 (+2.19%) ▲|QCOM176.88+0.48 (+0.27%) ▲|RTX198.12+0.57 (+0.29%) ▲|SBUX99.22-0.82 (-0.82%) ▼|SCHW107.33+0.79 (+0.74%) ▲|SO87.75-0.59 (-0.67%) ▼|SPG204.67+0.14 (+0.07%) ▲|T25.55+0.40 (+1.59%) ▲|TMO603.18-2.51 (-0.41%) ▼|TMUS177.16-0.18 (-0.10%) ▼|TSLA363.56-4.25 (-1.16%) ▼|TXN258.82-2.77 (-1.06%) ▼|UBER72.56+1.48 (+2.08%) ▲|UNH388.28-4.78 (-1.22%) ▼|UNP285.78+1.04 (+0.37%) ▲|UPS99.97+0.75 (+0.76%) ▲|USB62.41+0.30 (+0.48%) ▲|V367.21-0.18 (-0.05%) ▼|VZ49.97+0.23 (+0.46%) ▲|WFC89.45-0.22 (-0.25%) ▼|WMT105.73-0.10 (-0.09%) ▼|XOM165.23+1.00 (+0.61%) ▲|
22.6 C
New York
Friday, September 11, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

Medline launches new ComfortTemp® Patient Warming System with blankets and gowns

System built to provide effective body-temperature control; features lock-in hose connection and flexible design NORTHFIELD, Ill., July 10, 2025 /PRNewswire/ -- Medline today officially announced the...

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)

Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS)Following this important...

miraDry® Secures EU MDR Certification and Expands Indications for Sweat, Odor, and Hair Reduction Across Europe

NEWPORT BEACH, Calif., July 10, 2025 /PRNewswire/ -- miraDry®, Inc., a global leader in underarm sweat and odor treatment, announced today it has now...

Canary Speech Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

HITRUST e1 Certification validates Canary Speech's commitment to foundational cybersecurity controls and information risk management PROVO, Utah, July 10, 2025 /PRNewswire/ -- Canary Speech, the...

Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)

Floorstocks, a leading financial media platform, has released an exclusive interview with Wellgistics Health Inc. (NASDAQ: WGRX) filmed at the Nasdaq

Study Finds Link Between Brain Injury and Criminal Behavior

Study shows criminality is associated with damage to a key brain pathway involved in emotional control and judgment  AURORA, Colo., July 10, 2025 /PRNewswire/ --...

Canopy and Commure Announce Strategic Partnership to Advance Staff Safety in Healthcare

SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) -- Canopy, a leader in wearable safety and real-time location systems (RTLS) for healthcare, and Commure, the company behind next-generation AI infrastructure for health systems, today announced a strategic partnership to enhance support for Commure Strongline customers and ensure continued innovation in staff safety.

Proven Nurse Leadership Program Now Open to the Public for the First Time

VERO BEACH, Fla., July 10, 2025 /PRNewswire/ -- As healthcare systems continue to face high turnover, burnout, and operational strain, Inspire Nurse Leaders® is proud...

Dr. Rod J. Rohrich Serves as Faculty at Facelift and Rhinoplasty Master Course in New York City

Dr. Rod J. Rohrich participated as a distinguished faculty member in the Facelift and Rhinoplasty Master Course in New York City, contributing lectures, live...

AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth

AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer rates are...

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer rates are...

Vessel Sealer Curved receives FDA clearance

Intuitive’s latest advanced energy instrument features a unique curved tip for enhanced precision 
Intuitive’s latest advanced energy instrument features a unique curved tip for enhanced precision

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at...

NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present new findings at the upcoming Alzheimer's Association International Conference (AAIC®) 2025 in Toronto. The presentations include a cost savings analysis of the use of pTau217 as a screening tool in Acumen’s Phase 2 ALTITUDE-AD trial of sabirnetug as well as a nonclinical study evaluating the relative selectivity of sabirnetug to targeting AβOs versus Aβ monomers. The conference will be held July 27-31, 2025, both in-person and online.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers